Surgery Shows Potential Survival Benefit in Metastatic HER2 Breast Cancer

Surgery Shows Potential Survival Benefit in Metastatic HER2+ Breast Cancer

10:46 EDT 25 Jun 2019 | OncLive

Ross Mudgway, discusses the importance of considering surgery for patients with stage IV HER2-positive breast cancer and addresses disparities in healthcare among different social groups.

More From BioPortfolio on "Surgery Shows Potential Survival Benefit in Metastatic HER2+ Breast Cancer"